Home/Investors/LYFE Capital

LYFE Capital

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

7

Top Stage

platform

Investment Focus

Surgery Oncology Immunology Metabolic Biologics Diagnostics Biologics (as a service provider)

Portfolio Companies

Company	Stage	Valuation	Focus
Edge Medical	commercial	—	Surgery
Zencore Biologics	platform	—	Oncology, Immunology
Laekna Therapeutics	phase-2	—	Oncology
Dizal Pharma	phase-2	—	Oncology, Immunology
3D Medicines	commercial	—	Oncology, Immunology
Bota Bio	platform	—	Metabolic, Biologics
Fapon Biotech	platform	—	Diagnostics, Biologics (as a service provider)
iSIA Bio-technology	preclinical	—	Oncology

Frequent Co-Investors

Qiming Venture Partners5 shared Hillhouse Capital3 shared Sequoia Capital China2 shared OrbiMed1 shared HongShan1 shared Temasek Holdings1 shared Boyu Capital1 shared 3H Health1 shared